Terms: = Prostate cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Staging
2 results:
1. HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancer.
Weissbach L; Stuerzebecher S; Mumperow E; Klotz T; Schnell D
World J Urol; 2016 May; 34(5):641-7. PubMed ID: 26373955
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation of foxa1 with the malignancy and progression of prostate cancer].
Feng W; Zhang HB; Wang YM; Hu JL
Zhonghua Nan Ke Xue; 2015 May; 21(5):414-9. PubMed ID: 26117938
[TBL] [Abstract] [Full Text] [Related]
